Xifaxanta 200mg Tablets, containing the active ingredient rifaximin, are a targeted treatment for adults experiencing travelers’ diarrhea not associated with fever, bloody stools, or significant dehydration. Specifically designed to combat bacterial infections within the intestinal tract without systemic absorption, Xifaxanta ensures effective relief without affecting other body parts. Its unique action against non-invasive strains of Escherichia coli (E. coli) makes it an essential travel companion for those exploring new destinations. The recommended dosage is one tablet every eight hours for three days, ensuring continuity of treatment for optimal results. Xifaxanta is not intended for children under 18 years, and caution is advised for patients with severe liver conditions or those taking warfarin, as interactions may require dose adjustments.